Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10014300 | 0.85 | FFAR1 (0.35) | ALDH1A1MAPTGFERPOLBCA2 | |
| SCHEMBL13267939 | 0.77 | KDM4E (0.40) | ALDH1A1MAPT | |
| SCHEMBL12293197 | 0.76 | LTB4R (0.38) | ALDH1A1MAPTGFERPOLBCA2 | |
| SCHEMBL18674518 | 0.73 | — | — | |
| SCHEMBL19177097 | 0.71 | TDP1 (0.43) | ALDH1A1MAPTCA2 | |
| SCHEMBL8224582 | 0.69 | MAOA (0.43) | ALDH1A1MAPTCA2 | |
| SCHEMBL18674515 | 0.68 | KMT2A (0.45) | MAPT | |
| SCHEMBL8755137 | 0.68 | LTB4R (0.39) | ALDH1A1MAPT | |
| SCHEMBL19169724 | 0.68 | HDAC8 (0.37) | ALDH1A1MAPTGFERPOLBCA2 | |
| SCHEMBL24454439 | 0.67 | MRGPRX4 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120045784-A1 | BIOTINIDASE ASSAY | Joachim Ngiamas trustee for Joachim Ngiam Trust Fund ABN | 2012-02-23 | — | — | US | disclosed |
| WO-2010106222-A2 | BIOTINIDASE ASSAY | WALLAC OY (FI) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045784-A1 | BIOTINIDASE ASSAY | BTD, CMBL, JMJD7 | ALDH1A1 687/4885MAPT 3994/4885GFER 1885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.